2022 Buick Encore GX Essence
1.3 L • I3 • FWD • AT
KL4MMFSL7NB008554
Sales history: 1
Highlights
Condition
Run and drive
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
1.3 L • I3 • FWD • AT
Odometer
45,758 mi ≈ 73,640 km
Primary damage
Rear end
Docs
AL • Salvage
Extra
Auction
VIN
KL4MMFSL7NB008554
Lot number
62138275
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Montgomery, AL
Description
Fuel type
Gasoline
Body color
Charcoal
Body type
SUV
Trim
Essence
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Buick models
2022 Buick Encore GX Essence • 1.3 L • I3 • FWD • Automatic • Copart Lot: 62138275 • VIN: KL4MMFSL7NB008554
Find out more about this 2022 Buick Encore GX Essence, available at the Copart salvage car auction as lot #62138275 in Montgomery, AL. This car has Rear end main damage. It is listed with Run and drive start condition code. Odometer shows 45,758 mi. This Charcoal Buick Encore GX SUV is equipped with Gasoline 1.3 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for KL4MMFSL7NB008554 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
